Boaz Wachtel
Follow
Get notifications in MyBN when activity occurs.
Boaz Wachtel
Chief Executive, Executive Director, Chair since 2022 / Roots Sustainable Agricultural Technologies
Most Notable Role
Boaz Wachtel is a certified clinical research manager and holds an MA in management and marketing from the University of Maryland.
He was the co-founder and former managing director of Phytotech Medical, Australia's first publicly traded medical cannabis company. He is also the co-founder of IMCPC - International Medical Cannabis Patient Coalition.
Mr Wachtel is an Israeli medical cannabis pioneer/activist, who formulated and assisted the Ministry of Health with the implementation of the National Medical Cannabis Program which is one of only three national programs in the world.
He is a frequent lecturer and adviser to governments, national committees, business and NGOs on medical cannabis program formulation, grow operations, international laws and UN drug convention compliance, as well as the founder and former chair of the Green Leaf Party, a political party for cannabis legalisation/medicalisation, human rights and ecology.
Mr Wachtel is the co-author of the Ibogaine - Treatment Manual and has published more than 25 articles, papers and three book chapters.
He was the co-founder and former managing director of Phytotech Medical, Australia's first publicly traded medical cannabis company. He is also the co-founder of IMCPC - International Medical Cannabis Patient Coalition.
Mr Wachtel is an Israeli medical cannabis pioneer/activist, who formulated and assisted the Ministry of Health with the implementation of the National Medical Cannabis Program which is one of only three national programs in the world.
He is a frequent lecturer and adviser to governments, national committees, business and NGOs on medical cannabis program formulation, grow operations, international laws and UN drug convention compliance, as well as the founder and former chair of the Green Leaf Party, a political party for cannabis legalisation/medicalisation, human rights and ecology.
Mr Wachtel is the co-author of the Ibogaine - Treatment Manual and has published more than 25 articles, papers and three book chapters.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 815th | Creso Pharma | 1% | -27% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
2020
Chief Executive, Executive Director, Chair since 2022
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Creso Pharma | $144.7m |
200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| REMUNERATION UPDATE: Non-Executive Director, Chair since 2022, Creso Pharma | 03 Nov 2020 |
